AMAG is a biopharmaceutical company focused on bringing therapeutics to market that provide clear benefits and help improve people’s lives, all while delivering value to our shareholders.
Headquartered in Waltham, Massachusetts, with locations in Tucson, Arizona, and San Bruno, California, our products support the health of patients in the areas of maternal and women’s health, anemia management and cancer supportive care. In addition, we help families preserve newborn stem cells, which are used today in transplant medicine for certain cancers and blood, immune and metabolic disorders and have the potential to play a valuable role in the ongoing development of regenerative medicine.
Along with driving organic growth of our products, we seek to leverage our existing commercial infrastructure with additional commercial-stage products in our two current therapeutic areas and may consider late-stage development assets or seek opportunities in new therapeutic areas.
Recent Event Webcasts
Q3 2017 AMAG Pharmaceuticals, Inc. Earnings Conference Call (Live)
November 02, 2017 at 8:00 a.m. ET
AMAG Pharmaceuticals, Inc. at Deutsche Bank Leveraged Finance Conference (Replay)
October 04, 2017 at 3:35 p.m. MT
AMAG Pharmaceuticals, Inc. at Cantor Fitzgerald Global Healthcare Conference (Replay)
September 27, 2017 at 2:50 p.m. ET